ViewRay announced the Czech Ministry of Health has approved the purchase of ViewRay’s MRIdian system to bring advanced MRI-guided radiation therapy to treat its cancer patients at the Military University Hospital Prague in the Czech Republic. This is the first and only hospital to offer the precision of MRIdian Stereotactic MRI-guided Adaptive Radiotherapy, or SMART, in the Czech Republic. The purchase was co-financed by the REACT-EU financial instrument and the founder’s contribution, the Ministry of Defense of the Czech Republic.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on VRAY:
